Yale researchers, in collaboration with NVIDIA and Moderna, are pioneering efforts in using quantum machine learning to accelerate drug discovery. Their work focuses on exploring quantum neural networks on quantum computers, with the potential to transform the pharmaceutical industry. A recent review article, co-authored by scientists from Yale, NVIDIA, and Moderna, delves into these innovations. Additional media coverage highlight the growing interest in the intersection of AI, quantum computing, and biotechnology.